Physician profile
Hannah Bailey
NPI 1659826956
$2,072.93
in general payments reported to CMS, 2019-2025
22 companies · $26.66 in 2025
The $26.66 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.09 · 2023: $961 · 2024: $1,063 · 2025: $26.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $547.43 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $344.18 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $175.28 | 2023-2024 | Breztri, Farxiga, Airsupra |
| Novartis Pharmaceuticals Corporation | $108.11 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $105.14 | 2023-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Glaxosmithkline, LLC. | $96.77 | 2023-2024 | Bexsero, Shingrix, Arexvy |
| Novo Nordisk INC | $95.29 | 2023-2024 | Ozempic, Rybelsus |
| Amgen INC. | $90.41 | 2023-2024 | Repatha, Otezla, Evenity |
| Xeris Pharmaceuticals, INC. | $89.36 | 2023 | Gvoke Hypopen |
| Exact Sciences Corporation | $65.14 | 2023-2024 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $62.61 | 2023-2024 | Ajovy, Austedo, Uzedy |
| Idorsia Pharmaceuticals US INC | $51.18 | 2022-2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $46.93 | 2024 | |
| Antares Pharma, INC. | $45.98 | 2024 | Xyosted |
| Pfizer INC. | $29.86 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $24.16 | 2024 | Activ.A.C. |
| Sanofi-Aventis U.S. LLC | $18.68 | 2024 | |
| Viiv Healthcare Company | $16.78 | 2023 | Apretude |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.46 | 2024 | Relistor |
| Corium, LLC | $15.04 | 2023 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $15.03 | 2023 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.11 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.